Skip to main content

Frost & Sullivan Forecast Growth, Changes in Reagent Market

NEW YORK, Feb. 20-Revenues for biomedical research reagents in the United States climbed to $981 million last year and may be worth more than $2 billion by 2007, according to a new report from Frost & Sullivan.


The report, "U.S. Research Biochemical Markets," tracks the growth of demand for biochemicals like antibodies and enzymes that are used in immunochemistry, cell culture work and genomic research.


The market is strong, but the report warns that it is also changing rapidly. Patent expirations are transforming the business. As patents expire, reagents become more widely available as products. Competition intensifies, prices drop, and profit margins can dwindle.


As a result, biochemical makers will face pressure unless they find ways to protect their patents and intellectual property.


One strategy: to use old products in new combination technologies.


Another strategy: strengthening brand image. "Market leaders in research biochemicals industry have very well-respected, long standing brand names," said Frost & Sullivan analyst Brad Peters in a statement released by the company.


The consulting company also recognized six companies in the biochemical industry with "Marketing Engineering Awards": Applied Biosystems, Invitrogen, New England Biolabs, NuGEN Technologies, Promega, and Roche Applied Science.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.